Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection - Wikidata - wikimedia - TriplyDB

Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection

Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection

http://www.wikidata.org/entity/Q33797936

about

In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle.Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.In Vivo Assessment of Phage and Linezolid Based Implant Coatings for Treatment of Methicillin Resistant S. aureus (MRSA) Mediated Orthopaedic Device Related Infections.In vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin.Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome Against Experimental Catheter-Associated Biofilm Infection Due to Staphylococcus aureus In Vivo Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Streptococcus suis Serotype 2 at Varied Initial Inoculum Sizes.Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model.Dose Assessment of Cefquinome by Pharmacokinetic/Pharmacodynamic Modeling in Mouse Model of Staphylococcus aureus Mastitis Plasma and synovial fluid pharmacokinetics of cefquinome following the administration of multiple doses in horses.Activity of cefquinome against extended-spectrum β-lactamase-producing Klebsiella pneumoniae in neutropenic mouse thigh model.Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity.Development of methionyl-tRNA synthetase inhibitors as antibiotics for Gram-positive bacterial infections.Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus).In vivo activity of cefquinome against Riemerella anatipestifer using the pericarditis model in the duck.Pharmacokinetics, bioavailability and PK/PD relationship of cefquinome for Escherichia coli in Beagle dogs.Cefquinome-loaded microsphere formulations against Klebsiella pneumonia infection during experimental infections.

P2860

Q28552364-247C78DF-39DF-43FD-8BD2-1B84D6DFEA38 Q35712872-D82C0027-36F3-4387-A34A-725872BAC5AC Q35750265-7B7CAF60-6E0B-4191-BACB-B357BBFA5141 Q35859460-6A3293C1-61FF-4CDC-BEA1-CF9FE9C00EEC Q36059113-7F465627-D3E0-426F-9AB8-24730672FE30 Q36187937-91609DA4-D2ED-4894-8DB1-7C4640602305 Q36437850-9744BD04-0372-4306-ACF3-6D2F2EE0578B Q36571798-413A2650-2322-46D7-A00E-7890AB07FF74 Q36976649-7EF49435-80C2-4E00-A9C4-2E6D4F6746BB Q37318043-67779135-E9FE-49AB-9B7D-953C87CB0AAB Q39376296-71AD0F5B-FB83-4B66-8ABA-3E6069C87A52 Q39451172-539A1656-4BD6-40D7-9D17-E7E1607CAC85 Q40045003-13AD1D27-9DA4-481A-845F-CFC3CEC193E1 Q40077119-2BE9D634-513A-471B-BCED-D90FE1296EFD Q40115346-EF352825-511C-43BE-B502-44E37F7C11CB Q40330083-DFD4B0AB-280C-40B5-A9FB-A01A9BEE5481 Q41208996-6E392EA9-3A62-46E0-96F2-BE3C2DAAE2DA Q54236833-270F9982-1542-49F1-A96A-C120DAFD2EF8

P2860

Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection

http://www.wikidata.org/entity/Q33797936

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Pharmacodynamics of cefquinome ...... taphylococcus aureus infection

@ast

Pharmacodynamics of cefquinome ...... taphylococcus aureus infection

@en

type

label

Pharmacodynamics of cefquinome ...... taphylococcus aureus infection

@ast

Pharmacodynamics of cefquinome ...... taphylococcus aureus infection

@en

prefLabel

Pharmacodynamics of cefquinome ...... taphylococcus aureus infection

@ast

Pharmacodynamics of cefquinome ...... taphylococcus aureus infection

@en

P1433

Q33797936-28CFBDD9-3B29-4D6C-8AD4-ED8CE4B1A451

P1476

Q33797936-8075623F-B457-46CC-A9AE-9347F5807DAA

P2093

Q33797936-1787CC89-D4D4-478C-B6CF-3AD69AE18604

Q33797936-1A1F84E8-65D9-41C8-B530-C2DADBF004DA

Q33797936-A6D1BFF2-9465-4BF1-B251-B1ED2CE1728D

Q33797936-D9D49081-3E6A-4E0C-B597-65DDDBD7FF15

Q33797936-EDC58F06-2F4D-42FD-AFA4-98816D0E1FDA

P2860

Q33797936-1CCFF3C4-147C-46BD-BA46-C09DCBBE40C5

Q33797936-205F4944-0C44-4868-8CBD-9D3E78F32BA6

Q33797936-272774CF-D3DD-45C3-BC31-EC4048D2E6FC

Q33797936-5C3039B9-BE9C-4BFC-9ABB-9CE4DDC005E6

Q33797936-6B9B89A1-B5CD-4BEF-8F25-DB5ACD4022C2

Q33797936-70DB17D2-796E-4F7C-B92C-8D2794343F72

Q33797936-7917212A-7242-4B14-AC0F-2C5CF54BB09D

Q33797936-7A285582-E89D-4853-9A84-0FECCE7F6600

Q33797936-85920B4E-F234-445A-9762-E05823A1E362

Q33797936-8948E6BD-7D12-4A9E-84DF-BB49F34A2EE4

P304

Q33797936-32DB26EF-1D22-439C-826B-D0030BDDEFF8

P31

Q33797936-DD0D72D8-F145-4632-B5C0-B1F1D9FD8E62

P356

Q33797936-81FD811C-9E40-4D14-B23D-E0146F140FAE

P407

Q33797936-6BC91703-2472-4450-BF8D-442F8BA49DB3

P433

Q33797936-5416E881-399F-4E4E-925B-AB140C5226B4

P478

Q33797936-BFC7740D-D153-4490-93DE-1BE1C6052532

P577

Q33797936-797107CB-0766-44AE-978C-19D4E5165987

P5875

Q33797936-7FCDA593-495B-407D-83AB-D8788E7FDE2D

P698

Q33797936-60DA5CB3-47F8-4C6D-9AB0-F0D743E39BD7

P932

Q33797936-ECD3D667-BF19-4CCB-8698-3DEB8FC3B3CB

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pharmacodynamics of cefquinome ...... taphylococcus aureus infection

@en

P2093

Chaoping Liang

http://www.w3.org/2001/XMLSchema#string

Huanzhong Ding

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Qi Shan

http://www.w3.org/2001/XMLSchema#string

Zhenling Zeng

http://www.w3.org/2001/XMLSchema#string

P2860

Commercially distributed meat as a potential vehicle for community-acquired methicillin-resistant Staphylococcus aureus

Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin

In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005

Methicillin resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene.

Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations.

Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters.

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.

Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid.

P304

3008-3012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01666-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260682832

http://www.w3.org/2001/XMLSchema#string

P698

24614373

http://www.w3.org/2001/XMLSchema#string

P932

4068449

http://www.w3.org/2001/XMLSchema#string